144 related articles for article (PubMed ID: 16013492)
1. [Expression, identification and bioactivity characterization of an anti-CD3/anti-CD20 bispecific single-chain antibody].
Yu R; Li SC; Wu BC; Liu H; Ye LL; Chen ZL
Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):289-93. PubMed ID: 16013492
[TBL] [Abstract][Full Text] [Related]
2. [Biologic activity of bispecific single chain antibody against human gamma-seminoprotein and CD3 molecule].
Wang D; Wang H; Wu GJ; Wu WZ; Yang SL; Lin WH; Tan JM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):500-3. PubMed ID: 16806016
[TBL] [Abstract][Full Text] [Related]
3. [Expression and immunological activity of an anti-CD3×VEGFR2 bispecific single-chain antibody].
Dai LJ; Yan CW; Li SZ; Chen L; Li XY; Shan RH; Yu XW; Tang XB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):883-6. PubMed ID: 21806887
[TBL] [Abstract][Full Text] [Related]
4. [In vitro cytolysis of B-lymphoma cells mediated by an anti-CD3/anti-CD20 bispecific single-chain antibody].
Yu R; Li SC; Wu BC; Liu H; Ye LL; Liu XM; Wang QW; Chen ZL
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):384-90. PubMed ID: 16755915
[TBL] [Abstract][Full Text] [Related]
5. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
6. Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabody.
Xiong D; Xu Y; Liu H; Peng H; Shao X; Lai Z; Fan D; Yang M; Han J; Xie Y; Yang C; Zhu Z
Cancer Lett; 2002 Mar; 177(1):29-39. PubMed ID: 11809528
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of a bispecific anti-CD20 antibody with potent antitumor activity against B-cell lymphoma.
Li B; Zhang X; Shi S; Zhao L; Zhang D; Qian W; Zheng L; Gao J; Wang H; Guo Y
Cancer Res; 2010 Aug; 70(15):6293-302. PubMed ID: 20631068
[TBL] [Abstract][Full Text] [Related]
8. Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma.
Lu CY; Chen GJ; Tai PH; Yang YC; Hsu YS; Chang M; Hsu CL
Biochem Biophys Res Commun; 2016 May; 473(4):808-813. PubMed ID: 27040766
[TBL] [Abstract][Full Text] [Related]
9. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies.
Sun LL; Ellerman D; Mathieu M; Hristopoulos M; Chen X; Li Y; Yan X; Clark R; Reyes A; Stefanich E; Mai E; Young J; Johnson C; Huseni M; Wang X; Chen Y; Wang P; Wang H; Dybdal N; Chu YW; Chiorazzi N; Scheer JM; Junttila T; Totpal K; Dennis MS; Ebens AJ
Sci Transl Med; 2015 May; 7(287):287ra70. PubMed ID: 25972002
[TBL] [Abstract][Full Text] [Related]
11. Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels.
Stanglmaier M; Faltin M; Ruf P; Bodenhausen A; Schröder P; Lindhofer H
Int J Cancer; 2008 Sep; 123(5):1181-9. PubMed ID: 18546289
[TBL] [Abstract][Full Text] [Related]
12. The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells.
Tang P; Li L; Zhou Y; Shen CC; Kang YH; Yao YQ; Yi C; Gou LT; Yang JL
Biotechnol Appl Biochem; 2014; 61(4):376-84. PubMed ID: 24329807
[TBL] [Abstract][Full Text] [Related]
13. [Study on p53 tetramerization domain in improving functional affinity and biological activity of antibody].
Wang D; Wu GJ; Tan JM; Wang H
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):479-82. PubMed ID: 15854555
[TBL] [Abstract][Full Text] [Related]
14. In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model.
De Jonge J; Heirman C; de Veerman M; Van Meirvenne S; Moser M; Leo O; Thielemans K
J Immunol; 1998 Aug; 161(3):1454-61. PubMed ID: 9686611
[TBL] [Abstract][Full Text] [Related]
15. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
[TBL] [Abstract][Full Text] [Related]
16. Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE class.
Brischwein K; Parr L; Pflanz S; Volkland J; Lumsden J; Klinger M; Locher M; Hammond SA; Kiener P; Kufer P; Schlereth B; Baeuerle PA
J Immunother; 2007; 30(8):798-807. PubMed ID: 18049331
[TBL] [Abstract][Full Text] [Related]
17. Improvement in soluble expression levels of a diabody by exchanging expression vectors.
Liu F; Chen Z; Jiang W; Yang C; Xiong D; Zhu Z
Protein Expr Purif; 2008 Nov; 62(1):15-20. PubMed ID: 18667166
[TBL] [Abstract][Full Text] [Related]
18. A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DR.
Zeng J; Liu R; Wang J; Fang Y
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1899-907. PubMed ID: 25773122
[TBL] [Abstract][Full Text] [Related]
19. [Construction and expression of diabody [CD3 x Pgp] without Etag].
Liu JN; Gao YD; Wang JH; Shao XF; Fan DM; Ji Q; Xiong DS; Yang CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):946-9. PubMed ID: 17908506
[TBL] [Abstract][Full Text] [Related]
20. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110.
Deisting W; Raum T; Kufer P; Baeuerle PA; Münz M
PLoS One; 2015; 10(10):e0141669. PubMed ID: 26510188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
